The Heart of Midlands Manufacturing is Reborn on a Small Scale
Inanovate, currently located at the University’s Research Park, was founded in 2005 as a spin-off from the University’s Nanoscale Physics Research Laboratory and its mission is to make accurate cancer screening affordable and available to everyone.
The company’s powerful cancer biomarker screening invention is being used to develop diagnostic and monitoring tests for prostate and ovarian cancer with improved accuracy. These new tests are now undergoing final validation with clinical partners, and full clinical trials are due to begin later this year.
Inanovate also has a base in North Carolina, USA, and its expertise crosses business, biology, chemistry, physics and nano-scale engineering. The new technology combines nano-scale surface technologies, protein screening procedures and protein biomarker content with cutting edge expertise and facilities to create advanced systems for detecting cancer related protein biomarkers.
Dr David Ure, Managing Director of Inanovate and University of Birmingham physics graduate, said, ‘With Inanovate’s biotech/diagnostic applications well advanced and strong market pull emerging from the US we are looking forward to our move to Longbridge Innovation Centre, both to consolidate our position within the biotech market and to expand our work into additional non-bio applications such as catalysis and nano-particle research. We see the strong materials’ expertise in the Midlands region as a key component in our development plans within these markets.’
Professor Richard Palmer, Head of the University of Birmingham’s Nanoscale Physics Research Laboratory and inventor of the technology underpinning Inanovate, said, ‘I am delighted that Inanovate is moving to Longbridge. Longbridge is famous for the Mini which was all about technical innovation in a small package – nanotechnology is the same, but on a much smaller scale. I’d always hoped that the research we’ve been pursuing for 15 years would make an impact on regional regeneration.’
Pam Waddell, Director of Birmingham Science City, said, ‘The welcome success of Inanovate illustrates how Birmingham Science City, the Central Technology Belt and other initiatives are creating an environment that supports the development of a vibrant knowledge-based economy in the West Midlands. Long-term investment in the underpinning research, as well as the finances and infrastructure to support growing businesses, are playing a crucial role in realising the potential economic impact of nanotechnology and many other areas of science and technology in the region and beyond.’
Notes to Editors
1. A subsidiary of Inanovate, Birmingham Instruments Ltd, has been established to pursue additional non-bio applications of Inanovate’s nano-particle surface patterning and to provide cluster beam instruments to the international R&D market. Birmingham Instruments Ltd will be co-located at Inanovate’s Longbridge facilities.
2. The Nanoscale Physics Research Laboratory (NPRL) was founded in 1994 as the first centre for nanoscience in the UK.
3. The University of Birmingham is a partner in the Central Technology Belt which includes Longbridge.
4. The University of Birmingham is a partner in the Birmingham Science City project supported by AWM. Birmingham Science City is a region-wide partnership of public sector, businesses and the research base, which is facilitating the use of science and technology to improve the quality of life and prosperity of the West Midlands. Funded by Advantage West Midlands, Birmingham Science City’s aim is to create strategies to exploit centres of world-class scientific research, by developing relevant activities for sustainable economic and social benefit.
For further information
Kate Chapple, Press officer, University of Birmingham, tel 0121 414 2772 or 07789 921164.
*To visit the University of Birmingham website, click here.*